Massive Bio Commercial Launch Press Release
Manhattan-based startup brings next-generation testing and treatment recommendations from academia to community oncologists starting June 1 and announces it this press release about commercial launch.
Recent Posts
- Guidance by NIH, CDC and FDA to Coronavirus Pandemic in the United States of America
- Guidance to Sponsors on How to Manage Clinical Trials during the COVID-19 Pandemic by European Union
- Our Response to Coronavirus Pandemic and Guidance to Cancer Patients
- Interview: Selin Kurnaz, Massive Bio
- SYNERGY-AI Based Precision Oncology Clinical Trial Matching
- Artificial Intelligence In Cancer Therapy
- Patient Support in Precision Cancer Care